These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11731663)

  • 1. Fatty acids, alpha-fetoprotein, and cystic fibrosis.
    Mizejewski GJ; Pass KA
    Pediatrics; 2001 Dec; 108(6):1370-3. PubMed ID: 11731663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis.
    Coste TC; Armand M; Lebacq J; Lebecque P; Wallemacq P; Leal T
    Clin Biochem; 2007 May; 40(8):511-20. PubMed ID: 17316592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can 5-methyltetrahydrofolate modify the phospholipid fatty acid pattern in cystic fibrosis pediatric patients?
    Scambi C; Guarini P; De Franceschi L; Bambara LM
    J Cyst Fibros; 2006 Aug; 5(3):197-9. PubMed ID: 16516563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis.
    Al-Turkmani MR; Freedman SD; Laposata M
    Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):309-18. PubMed ID: 18036797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis.
    De Vizia B; Raia V; Spano C; Pavlidis C; Coruzzo A; Alessio M
    JPEN J Parenter Enteral Nutr; 2003; 27(1):52-7. PubMed ID: 12549599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid imbalance might lead to novel treatments for CF.
    Greener M
    Mol Med Today; 2000 Feb; 6(2):47-8. PubMed ID: 10652475
    [No Abstract]   [Full Text] [Related]  

  • 7. Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis.
    Ranieri E; Ryall RG; Morris CP; Nelson PV; Carey WF; Pollard AC; Robertson EF
    BMJ; 1991 May; 302(6787):1237-40. PubMed ID: 2043846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha-Fetoprotein and cystic fibrosis.
    Beaudry PH; Bergsteinsson H; Dupont C; Wong HC; Shuster J; Desmond K; Gold P
    Clin Invest Med; 1982; 5(1):45-7. PubMed ID: 6180858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of cystic fibrosis with abnormalities in fatty acid metabolism.
    Freedman SD; Blanco PG; Zaman MM; Shea JC; Ollero M; Hopper IK; Weed DA; Gelrud A; Regan MM; Laposata M; Alvarez JG; O'Sullivan BP
    N Engl J Med; 2004 Feb; 350(6):560-9. PubMed ID: 14762183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional assessment of infants with cystic fibrosis diagnosed through screening.
    Mischler EH; Marcus MS; Sondel SA; Laxova A; Carey P; Langhough R; Farrell PM
    Pediatr Pulmonol Suppl; 1991; 7():56-63. PubMed ID: 1782132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scots launch cystic fibrosis screening for newborns.
    Pract Midwife; 2003 Apr; 6(4):10. PubMed ID: 12715497
    [No Abstract]   [Full Text] [Related]  

  • 12. Fatty acids in blood and intestine following docosahexaenoic acid supplementation in adults with cystic fibrosis.
    Jumpsen JA; Brown NE; Thomson AB; Paul Man SF; Goh YK; Ma D; Clandinin MT
    J Cyst Fibros; 2006 May; 5(2):77-84. PubMed ID: 16507353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid metabolism in cystic fibrosis.
    Strandvik B
    N Engl J Med; 2004 Feb; 350(6):605-7. PubMed ID: 14762189
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum alpha - fetoprotein levels in patients with cystic fibrosis and their parents and siblings.
    Chandra RK; Madhavankutty K; Way RC
    Br Med J; 1975 Mar; 1(5960):714-6. PubMed ID: 47779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid supplements improve respiratory, inflammatory and nutritional parameters in adults with cystic fibrosis.
    Olveira G; Olveira C; Acosta E; Espíldora F; Garrido-Sánchez L; García-Escobar E; Rojo-Martínez G; Gonzalo M; Soriguer F
    Arch Bronconeumol; 2010 Feb; 46(2):70-7. PubMed ID: 20045240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin, growth hormone and alpha-fetoprotein in children with cystic fibrosis.
    Biswas S; Norman AP; Baffoe G; Graves L
    Clin Chim Acta; 1976 Jun; 69(3):541-2. PubMed ID: 59645
    [No Abstract]   [Full Text] [Related]  

  • 17. Low linoleic and high docosahexaenoic acids in a severe phenotype of transgenic cystic fibrosis mice.
    Strandvik B; O Neal WK; Ali MA; Hammar U
    Exp Biol Med (Maywood); 2018 Mar; 243(5):496-503. PubMed ID: 29513100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new strategy of neonatal screening for cystic fibrosis. The association of immunoreactive trypsin and molecular biology in dried blood].
    Laroche D; Peres O; Briard ML; Lemonnier F; Pasquet-Ferre C; Blandin C; Travert G; Fernandez Y
    Arch Fr Pediatr; 1990 Apr; 47(4):251-3. PubMed ID: 2363611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth evaluation at one year of life in infants with cystic fibrosis diagnosed by neonatal screening.
    Pederzini F; D'Orazio C; Tamiazzo G; Faraguna D; Giglio L; Mastella G
    Pediatr Pulmonol Suppl; 1991; 7():64-8. PubMed ID: 1782133
    [No Abstract]   [Full Text] [Related]  

  • 20. Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels.
    Rock MJ; Mischler EH; Farrell PM; Wei LJ; Bruns WT; Hassemer DJ; Laessig RH
    Pediatrics; 1990 Jun; 85(6):1001-7. PubMed ID: 2187173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.